Mechanisms of cellular fibrosis associated with cancer regimen-related toxicities

Frontiers in Pharmacology

Volumn 5 MAR, Issue , 2014, Pages

  Mancini, Maria L ^a   Sonis, Stephen T ^a  

^a Biomodels   (United States)

Author keywords

Chemotherapy toxicity; Fibrosis; Oral mucositis; Proctitis; Pulmonary fibrosis; Radiation dermatitis; Radiation therapy; TGF

Indexed keywords

AMIFOSTINE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BLEOMYCIN; CISPLATIN; COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; GAMMA INTERFERON; MESALAZINE; METRONIDAZOLE; NARCOTIC ANALGESIC AGENT; PALIFERMIN; SMAD3 PROTEIN; STEROID; SUCRALFATE; SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE MIMETICS; THIOL AMIFOSTINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXM1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANTIOXIDANT ACTIVITY; APHTHOUS STOMATITIS; ARGON PLASMA COAGULATION; AUTOTRANSPLANTATION; BACTERIAL COLONIZATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL PROLIFERATION; CELLULAR FIBROSIS; CYTOTOXICITY; DISEASE ASSOCIATION; DRUG CHOICE; DRUG POTENCY; DRUG TREATMENT FAILURE; ENTERIC FEEDING; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIZATION; ERYTHEMA; ESOPHAGUS STENOSIS; EXTRACELLULAR MATRIX; FIBROSIS; GASTROSTOMY; HEAD AND NECK CANCER; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; INTESTINAL BLEEDING; INTESTINE ENDOSCOPY; INTESTINE ISCHEMIA; INTESTINE NECROSIS; LOW DRUG DOSE; LUNG FIBROSIS; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUTH PAIN; MOUTH ULCER; NONHUMAN; ORAL MUCOSITIS; PAIN; PATHOPHYSIOLOGY; PHENOTYPE; PROCTITIS; PROTEIN EXPRESSION; PROTEIN SECRETION; RADIATION DERMATITIS; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PNEUMONIA; RADIATION PROTECTION; RECTUM HEMORRHAGE; REVIEW; SIGNAL TRANSDUCTION; SKIN FIBROSIS; TELANGIECTASIA; TENESMUS; TISSUE SPECIFICITY; TRISMUS; UNSPECIFIED SIDE EFFECT; WOUND HEALING;

EID: 84897938063     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00051     Document Type: Review

References (84)

1. Abdollani, A., Griggs, D. W., Zieher, H., Roth, A., Lipson, K. E., Saffrich, R., et al. (2005). Inhibition of alpha (v) beta 3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy. Clin. Cancer Res. 11, 6270-6279. doi: 10.1158/1078-0432.CCR-04-1223.
2. Almeida, C., Nagarajan, D., Tian, J., Leal, S. W., Wheeler, K., Munley, M., et al. (2013). The role ofPLoS ONE alveolar epithelium in radiation-induced lung injury. 8:e53628. doi: 10.1371/journal.pone.0053628.
3. Andersson-Sjöland, A., Nihlberg, K., Eriksson, L., Bjermer, L., and Westergren-Thorsson, G. (2011). Fibrocytes and the tissue niche in lung repair. Respir. Res. 12, 76. doi: 10.1186/1465-9921-12-76.
4. Andreassen, C. N., Overgaard, J., and Alsner, J. (2013). Independent prospective validation of a predictive test for risk of radiation induced fibrosis on the gene expression pattern in fibroblasts irradiated in vitro. Radiother. Oncol. 108, 469-472. doi: 10.1016/j.radonc.2013.08.029.
5. Ara, G., Watkins, B. A., Zhong, H., Hawthorne, T. R., Karkaria, C. E., Sonis, S. T., et al. (2008). Valifermin (rhFGF-20) reduces the severity and duration of hamster cheek pouch mucositis induced by fractionated radiation. Int. J. Radiat. Biol. 84, 401-412. doi: 10.1080/09553000802007601.
6. Ashcroft, G., Yang, X., Glick, A. B., Weinstein, M., Letterio, J. L., Mizel, D. E., et al. (1999). Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat. Cell Biol. 1, 260-266. doi: 10.1038/12971.
7. Balli, D., Ustiyan, V., Zhang, Y., Wang, I. C., Masino, A. J., Ren, X., et al. (2013). Foxm1 transcription factor is required for lung fibrosis and epithelial-to-mesenchymal transition. EMBO J. 32, 231-244. doi: 10.1038/emboj.2012.336.
8. Barnett, G. C., Elliott, R. M., Alsner, J., Andreassen, C. N., Abdelhay, O., Burnet, N. G., et al. (2012). Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity. Radiother. Oncol. 105, 289-295. doi: 10.1016/j.radonc.2012.10.017.
9. Bey, E., Prat, M., Duhamel, P. D., Benderitter, M., Brachet, M., Trompier, F., et al. (2010). Emerging therapy for improving wound repair of sever radiation burns using local bone marrow-derived stem cell administrations. Wound Repair Regen. 18, 50-58. doi: 10.1111/j.1524-475X.2009.00562.x.
10. Blirando, K., Milliat, F., Martelly, I., Sabourin, J. C., Benderitter, M., and François, A. (2011). Mast cells are an essential component of human radiation proctitis and contribute to experimental colorectal damage in mice. Am. J. Pathol. 178, 640-651. doi: 10.1016/j.ajpath.2010.10.003.
11. Boerma, M., Wang, J., Sridharan, V., Herbert, J. M., and Hauer-Jensen, M. (2013). Pharmacological induction of transforming growth factor-beta1 in rat models enhances radiation injury in the intestine and heart. PLoS ONE 8:e70479. doi: 10.1371/journal.pone.0070479.
12. Brown, K., and Rzucidlo, E. (2011). Acute and chronic radiation injury. J. Vasc. Surg. 53, 15S-21S. doi:10.1016/j.jvs.2010.06.175.
13. Brunn, T., and Fletcher, C. D. (2006). Postradiation vascular proliferations: an increasing problem. Histophathology 48, 106-114. doi: 10.1111/j.1365-2559.2005.02293.x.
14. Burdelya, L. G., Gleiberman, A. S., Toshkov, I., Aygun-Sunar, S., Bapardekar, M., Manderscheid-Kern, P., et al. (2011). Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 83, 228-234. doi: 10.1016/j.ijrobp.2011.05.055.
15. Carver, J. R., Shapiro, C. L., Ng, A., Jacobs, L., Schwartz, C., Virgo, K. S., et al. (2007). American society of clinical oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J. Clin. Oncol. 25, 3991-4008. doi: 10.1200/JCO.2007.10.9777.
16. Caughey, G. H. (2007). Mast cell typtases and chymases in inflammation and host defense. Immunol. Rev. 217, 141-154. doi: 10.1111/j.1600-065X.2007.00509.x.
17. Chan, R. J., Larsen, E., and Chan, P. (2012). Re-examining the evidence in radiation dermatitis management literature: an overview and a critical appraisal of systematic reviews. Int. J. Radiat. Oncol. Biol. Phys. 84, e357-e362. doi: 10.1016/j.ijrobp.2012.05.009.
18. Chen, E., Greenlee, B., Wills-Karp, M., and Moller, D. R. (2001). Attenuation of lung inflammation and fibrosis in interferon-γ-deficient mice after intratracheal bleomycin. Am. J. Respir. Cell Mol. Biol. 24, 545-555. doi: 10.1165/ajrcmb.24.5.4064.
19. Counter, S. F., Froese, D. P., and Hart, M. J. (1999). Prospective evaluation of formalin therapy for radiation proctitis. Am. J. Surg. 177, 396-398. doi: 10.1016/S0945-053X(00)00077-9.
20. Eckes, B., Zigrino, P., Kessler, D., Holtkötter, O., Shephard, P., Mauch, C., et al. (2000). Fibroblast-matrix interactions in wound healing and fibrosis. Matrix Biol. 19, 325-332. doi: 10.1016/S0945-053X(00)00077-9.
21. Elting, L. S., Keefe, D. M., Sonis, S. T.,Garden, A. S., Spijkervet, F. K., Barasch, A., et al. (2008). Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer 113, 2704-2713. doi: 10.1002/cncr.23898.
22. Fajardo, L. F. (2005). The pathology of ionizing radiation as defined by morphologic patterns. Acta Oncol. 44, 13-22. doi: 10.1080/02841860510007440.
23. Flanders, K. C., Major, C. D., Arabshahi, A., Aburime, E. E., Okada, M. H., Fujii, M., et al. (2003). Interference with transforming growth factor-b/Smad3 signaling results in accelerated healing of wounds in previously irradiated skin. Am. J. Pathol. 163, 2247-2257. doi: 10.1016/S0002-9440(10)63582-1.
24. Flanders, K. C., Sullivan, C. D., Fujii, M., Sowers, A., Anzano, M. A., Arabshahi, A., et al. (2002). Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. Am. J. Pathol. 160, 1057-1068. doi: 10.1016/S0002-9440(10)64926-7.
25. Fujita-Yoshigaki, J., and Qi, B. (2009). Parotid acinar cells transiently change to duct-like cells during epithelial-mesenchymal transition. J. Med. Invest. 56, 258-259. doi: 10.2152/jmi.56.258.
26. Gao, F., Fish, B. L., Szabo, A., Doctrow, S. R., Kma, L., Molthen, R. C., et al. (2012). Short-term treatment with a SOD/catalase mimetic, EUK-207, mitigates pneumonitis and fibrosis after single-dose total-body or whole-thoracic irradiation. Radiat. Res. Soc. 178, 468-480. doi: 10.1667/RR2953.2.
27. Ghosh, A., Wei, J., Wu, M., and Varga J. (2008). Constitutive Smad signaling and Smad-dependent collagen gene expression in mouse embryonic fibroblasts lacking peroxisome proliferator-activated receptor-γ. Biochem. Biophys. Res. Comm. 374, 231-236. doi: 10.1016/j.bbrc.2008.07.014.
28. Gurujeyalakshmi, G., and Giri, S. N. (1995). Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression. Exp. Lung Res. 21, 791-808. doi: 10.3109/01902149509050842.
29. Haboubi, N. Y., Schofield, P. F., and Rowland, P. L. (1988). The light and electron microscopic features of early and late phase radiation-induced proctitis. Am. J. Gastroenterol. 83, 1140-1144.
30. Han, G., Zhang, H., Xie, C. H., and Zhou, Y. F. (2011). Th2-like immune response in radiation-induced lung fibrosis. Oncol. Rep. 26, 383-388. doi: 10.3892/or.2011.1300.
31. Haselton, P. S., Carr, N., and Schofield, P. F. (1985). Vascular changes in radiation bowel disease. Histopathology 9, 517-534. doi: 10.1111/j.1365-2559.1985.tb02833.x.
32. Holmes, A., Abraham, D., Sa, S., Shiwen, X., Black, C. M., and Leask, A. (2001). CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J. Biol. Chem. 276, 10594-10601. doi: 10.1074/jbc.M010149200.
33. Hugh, R. P., and Pemberton, A. D. (2002). Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunol. 105, 373-390. doi: 10.1046/j.1365-2567.2002.01375.x.
34. Johnston, C. J., Williams, J. P., Okunieff, P., and Finkelstein, J. N. (2002). Radiation-induced pulmonary fibrosis: examination of chemokine and chemokine receptor families. Radiat. Res. 157, 256-265. doi: 10.1667/0033-7587(2002)157[0256:RIPFEO]2.0.CO;2.
35. Johnston, C. J., Wright, T. W., Rubin, P., and Finkelstein, J. N. (1998). Alterations in the expression of chemokine mRNA levels in fibrosis-resistant and-sensitive mice after thoracic radiation. Exp. Lung Res. 24, 321-337. doi: 10.3109/01902149809041538.
36. Kang, S., Chun, M., Jin, Y. M., Cho, M. S., Oh, Y. T., Ahn, B. O., et al. (2000). A rat model for radiation-induced proctitis. J. Korean Med. Sci. 15, 682-689.
37. Koukourakis, M. I., Panteliadou, M., Abatzoglou, I. M., Sismanidou, K., Sivridis, E., and Giatromanolaki, A. (2013). Postmastectomy hypofractionated and accelerated radiation therapy with and without subcutaneous amifostine cytoprotection. Int. J. Radiat. Oncol. Biol. Phys. 85, e7-e13. doi: 10.1016/j.ijrobp.2012.08.017.
38. Kouvaris, J., Kouloulias, V., and Vlahos, L. (2007). Amifostine: the first selective-target and broad-spectrum radioprotector. Oncologist 12, 738-747. doi: 10.1634/theoncologist.12-6-738.
39. Lataillade, J. J., Doucet, C., Bey, E., Carsin, H., Huet, C., Clairand, I., et al. (2007). New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen. Med. 2, 785-794. doi: 10.2217/17460751.2.5.785.
40. Lavrenkov, K., Christian, J. A., Partridge, M., Niotsikou, E., Cook, G., Parker, M., et al. (2007). A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer. Radiother. Oncol. 83, 156-162. doi: 10.1016/j.radonc.2007.04.005.
41. Leask, A., and Abraham, D. (2004). TGFβ Signaling and the fibrotic response. FASEB J. 18, 816-827. doi: 10.1096/fj.03-1273rev.
42. Leask, A., Holmes, A., Black, C. M., and Abraham, D. J. (2003). Connective tissue growth factor gene regulation. requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J. Biol. Chem. 278, 13008-13015. doi: 10.1074/jbc.M210366200.
43. Leiper, K., and Morris, A. I. (2007). Treatment of radiation proctitis. Clin. Oncol. 19, 724-729. doi: 10.1016/j.clon.2007.07.008.
44. Linard, C., Busson, E., Holler, V., Strup-Perrot, C., Lacave-Lapalun, J. V., Lhomme, B., et al. (2013). Repeated autologous bone marrow-derived mesenchymal stem cell injections improve radiation-induced proctitis in pigs. Stem Cells Transl. Med. 2, 916-927. doi: 10.5966/sctm.2013-0030.
45. Lyons, A., Crichton, S., and Pezier, T. (2013). Trismus following radiotherapy to the head and neck is likely to have distinct genotype dependent cause. Oral Oncol. 49, 932-936. doi: 10.1016/S0360-3016(00)00435-1.
46. Martin, M., Lefaix, J., and Delanian, S. (2000). TGF-β1 and radiation fibrosis: a master switch and a specific therapeutic target? Int. J. Radiat. Oncol. Biol. Phys. 47, 277-290. doi: 10.1016/S0360-3016(00)00435-1.
47. Massague, J. (2012). TGFβ signaling in context. Nat. Rev. Mol. Cell Biol. 13, 616-630. doi: 10.1038/nrm3434.
48. Mehta, V. (2005). Radiation pneumonitis and pulmonary fibrosis in non-small cell lung cancer: pulmonary function, prediction and prevention. Int. J. Radiat. Oncol. Biol. Phys. 63, 5-24. doi: 10.1016/j.ijrobp.2005.03.047.
49. Mori, R., Kondo, T., Ohshima, T., Ishida, Y., and Mukaida, N. (2002). Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB 16, 963-974. doi: 10.1096/fj.01-0776com.
50. Murakami, R., Baba, Y., Nishimura, R., Furusawa, M., Yokoyama, T., Yamashita, Y., et al. (1997). The effect of azelastine on acute radiation dermatitis in mice models. Int. J. Radiat. Oncol. Biol. Phys. 37, 907-911. doi: 10.1016/S0360-3016(96)00621-9.
51. Murray, L., Kramer, M., Hesson, D. P., Watkins, B. A., Fey, E. G., Argentieri, R. L., et al. (2010). Serum amyloid P ameliorates radiation-induced oral mucositis and fibrosis. Fibrogenesis Tissue Repair 3, 11. doi: 10.1186/1755-1536-3-11.
52. Nathan, C. F., Prendergast, T. J., Wiebe, M. E., Stanley, E. R., Platzer, E., Remold, H. G., et al. (1984). Activation of Human Macrophages. Comparison of other cytokines with interferon-gamma. J. Exp. Med. 160, 600-605. doi: 10.1084/jem.160.2.600.
53. Oh, C. J., Kim, J. Y., Choi, Y. K., Kim, H. J., Jeong, J. Y., Bae, K. H., et al. (2012). Dimethylfumarate attenuates renal fibrosis via NF-E2-Related factor 2-Mediated inhibition of transforming growth factor-β/Smad signaling. PLoS ONE 7:e45870. doi: 10.1371/journal.pone.0045870.
54. Okunieff, P., Cornelison, T., Mester, M., Liu, W., Ding, I., Chen, Y., et al. (2005). Mechanism and modification of gastrointestinal soft tissue response to radiation: role of growth factors. Int. J. Radiat. Oncol. Biol. Phys. 62, 273-278. doi: 10.1016/j.ijrobp.2005.01.034.
55. Pan, J., Su, Y., Hou, X., He, H., Liu, S., Wu, J., et al. (2012). Protective effect of recombinant protein SOD-TAT on radiation-induced injury in mice. Life Sci. 91, 89-93. doi: 10.1016/j.lfs.2012.06.003.
56. Paun, A., and Haston, C. K. (2012). Genomic and genome-wide association of susceptibility to radiation-induced fibrotic lung disease in mice. Radiother. Oncol. 105, 350-357. doi: 10.1016/j.radonc.2012.08.004.
57. Petrovski, S., Szoeke, C. E., Sheffield, L. J., D'souza, W., Huggins, R. M., and O'brien, T. J. (2009). Multi-SNP pharmacogenomic classifier is superior to single-SNP models for predicting drug outcome in complex diseases. Pharmacogenet. Genomics 19, 147-152. doi: 10.1097/FPC.0b013e32831d1dfa.
58. Piguet, P. F., Collart, M. A., Grau, G. E., Sappino, A. P., and Vassalli, P. (1990). Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 344, 245-247. doi: 10.1038/344245a0.
59. Radisky, D. (2005). Epithelial-mesenchyman transition. J.Cell Sci. 118, 4325-4326. doi: 10.1242/jcs.02552.
60. Rosai, J. (1996). "Acute pulmonary injury and interstitial pneumonia," in Ackerman's Surgical Pathology, 8th Edn, Vol. 1, ed. J Rosai (New York: Mosby), 358-359.
61. Rube, C., Uthe, D., Schmid, K. W., Richter, K. D., Wessel, J., Schuck, A., et al. (2000). Dose-dependent induction of transforming growth factor β (TGFβ) in the lung tissue of fibrosis-prone mice after thoracic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 47, 1033-1042. doi: 10.1016/S0360-3016(00)00482-X.
62. Ryan, J. (2012). Ionizing radiation: the good, the bad, and the ugly. J. Invest. Dermatol. 132, 985-993. doi: 10.1038/jid.2011.411.
63. Salvo, N., Barnes, E., van Draanen, J., Stacey, E., Mitera, G., Breen, D., et al. (2010). Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature. Curr. Oncol. 17, 94-112.
64. Sempowski, G., Borrello, M., Blieden, T. M., Barth, R. K., and Phipps, R. P. (1995). Fibroblast heterogeneity in the healing wound. Wound Repair Regen. 3, 120-131. doi: 10.1046/j.1524-475X.1995.30204.x.
65. Sheth, S., Bleibel, W., Thukral, C., A-Rahim, Y., Beldi, G., Csizmadia, E., et al. (2009). Heightened NTPDase-1/CD39 expression and angiogenesis in radiation proctitis. Purinergic Signal. 5, 321-326. doi: 10.1007/s11302-009-9154-2.
66. Silverman, S. Jr. (2007). Diagnosis and management of oral mucositis. J. Support. Oncol. 5(Suppl. 1), 13-21.
67. Skwarchuk, M., and Travis, E. (1998). Changes in histology and fibrogenic cytokines in irradiated colorectum of two murine strains. Int. J. Radiat. Oncol. Biol. Phys. 42, 169-178. doi: 10.1016/S0360-3016(98)00201-6.
68. Son, H.-N., Nam, J.-O., Kim, S., and Kim, I. S. (2013). Multiple FAS1 domains and the RGD motif of TGFBI act cooperatively to bind avβ3 integrin, leading to anti-angiogenic and anti-tumor effects. Biochim. Biophys. Acta Mol. Cell Res. 1833, 2378-2388. doi: 10.1016/j.bbamcr.2013.06.012.
69. Sonis, S. T. (2007). Pathobiology of mucositis: novel insights and opportunities. J. Support. Oncol. 5, 3-11.
70. Sonis, S. T. (2011). Oral mucositis in head and neck cancer. Am. Soc. Clin. Oncol. Educ. Book 236-240.
71. Sonis, S. T. (2013). Oral mucositis. Anticancer Drugs 47, 831-839.
72. Sonis, S. T., and Keefe, D. M. (2013). The Pathobiology of Cancer Regimen-Related Toxicities. New York: Springer. doi: 10.1007/978-1-4614-5438-0.
73. Sonis, S. T., Peterson, R. L., Edwards, L. J., Lucey, C. A., Wang, L., Mason, L., et al. (2000). Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol. 36, 373-381. doi: 10.1016/S1368-8375(00)00012-9.
74. Sonnylal, S., Xu, S., Jones, H., Tam, A., Sreeram, V. R., Ponticos, M., et al. (2013). Connective tissue growth factor causes EMT-like cell fate changes in vivo and in vitro. J. Cell Sci. 126, 2164-2175. doi: 10.1242/jcs.111302.
75. Symon, Z., Goldshmidt, Y., Picard, O., Yavzori, M., Ben-Horin, S., Alezra, D., et al. (2010). A murine model for the study of molecular pathogenesis of pathogenesis of radiation proctitis. Int. J. Radiat. Oncol. Biol. Phys. 76, 242-250. doi: 10.1016/j.ijrobp.2009.07.1736.
76. Thabut, G., Mal, H., Castier, Y., Groussard, O., Brugière, O., Marrash-Chahla, R., et al. (2003). Survival benefit of lung transplantation for patients with pulmonary fibrosis. J. Thorac. Cardiovasc. Surg. 126, 469-475. doi: 10.1016/S0022-5223(03)00600-7.
77. Tsoutsou, P., and Koukourakis, M. (2006). Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int. J. Radiat. Oncol. Biol. Phys. 66, 1281-1293. doi: 10.1016/j.ijrobp.2006.08.058.
78. Ueha, S., Shand, F., and Matsushima, K. (2012). Cellular and molecular mechanism of chronic inflammation-associated organ fibrosis. Front. Immunol. 3:71. doi: 10.3389/fimmu.2012.00071.
79. Venkov, C., Link, A., Jennings, J. L., Plieth, D., Inoue, T., Nagai, K., et al. (2007). A proximal activator of transcription in epithelial-mesenchymal transition. J. Clin. Invest. 117, 482-491. doi: 10.1172/JCI29544.
80. Vermorken, J. B., and Specenier, P. (2010). Optimal treatment for recurrent/metastatic head and neck cancer. Ann. Oncol. 21(Suppl. 7), vii252-vii261. doi: 10.1093/annonc/mdq453.
81. Wang, Q., Usinger, W., Nichols, B., Gray, J., Xu, L., Seeley, T. W., et al. (2011). Cooperative interaction of CTGF and TGF-b in animal models of fibrotic disease. Fibrogenesis Tissue Repair 4:4. doi: 10.1186/1755-1536-4-4.
82. Willis, B. C., Liebler, J. M., Luby-Phelps, K., Nicholson, A. G., Crandall, E. D., du Bois, R. M., et al. (2005). Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: a potential role in idiopathic pulmonary fibrosis. Am. J. Pathol. 166, 1321-1332. doi: 10.1016/S0002-9440(10)62351-6.
83. Wong, R. K., Bensadoun, R., Boers-Doets, C. B., Bryce, J., Chan, A., Epstein, J. B., et al. (2013). Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group. Support Care Cancer 21, 2933-2948. doi: 10.1007/s00520-013-1896-2.
84. Zhu, M. L., Wang, M., Shi, T. Y., Li, Q. X., Xi, P., Xia, K. Q., et al. (2013). No association between TGFβ1 polymorphisms and late radiotherapy toxicity: a meta-analysis. PLoS ONE 8:e76964. doi: 10.1371/journal.pone.0076964.